MLO State of the Industry Disease Management Survey


By Kara Nadeau, MLO Contributing Editor M


edical Laboratory Observer’s (MLO) third “State of the Industry” survey topic in 2022 is Disease Management. The majority of clinical laboratory professionals responding (93%) work in hospital labs. The survey fi ndings reveal higher testing volumes at a time when most labs are struggling with staff shortages. For many labs, changes made in diagnos- tic processes in response to the COVID-19 pandemic, such as supplier diversifi cation and increased space for molecular testing, have become a permanent way to cope with continued challenges.


28 AUGUST 2022 MLO-ONLINE.COM


In addition to the survey data, we present in- sights from U.S. clinical lab professionals on the disease management trends they are seeing in their testing facilities.


Fewer staff to process more tests The survey results show an increase in testing vol- umes across the board, with 67% of respondents saying their labs are processing more tests for respiratory-related diseases, 43% drugs of abuse, 36% sexually transmitted infections (STI)/sexually transmit- ted diseases (STD) and other sexually transmitted


Photo by Maksim Shmeljov @ adobestock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52